Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications

This cross-sectional study uses national prescription data to assess whether safety communications from the US Food and Drug Administration (FDA) issued in 2017 and 2018 were associated with changes in prescriptions for codeine and hydrocodone cough and cold medications to children and adolescents.

Detalles Bibliográficos
Autores principales: Chua, Kao-Ping, Conti, Rena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586901/
https://www.ncbi.nlm.nih.gov/pubmed/34762115
http://dx.doi.org/10.1001/jamanetworkopen.2021.34142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586901/
https://www.ncbi.nlm.nih.gov/pubmed/34762115
http://dx.doi.org/10.1001/jamanetworkopen.2021.34142

Ejemplares similares